Skip to main content

Advertisement

SpringerLink
Log in

Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

Thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) are important enzymes in the metabolism of 5-fluorouracil and possible predictive markers. We conducted this study to clarify if TS and DPD gene expressions are a prognostic indicator for intrahepatic cholangiocarcinoma (IHCC).

Methods

The subjects of this study were 21 patients with IHCC who had undergone surgical resection. Intratumoral TS and DPD mRNA expressions were examined using the Danenberg tumor profile method and classified into two groups according to the median value of each. We then compared the clinicopathological variables, including prognosis, between the high and low expression groups.

Results

Low DPD expression was correlated with macroscopic type, namely, mass-forming + infiltrative (P = 0.08). Postoperative survival rates in the low DPD expression group were significantly lower than those in the high DPD expression group. Multivariate analysis revealed macroscopic type to be an independent prognostic factor, whereas TS mRNA expression did not correlate with any clinicopathological variables, including prognosis.

Conclusions

Low DPD mRNA expression was related to macroscopic type and associated with poor prognosis. DPD mRNA expression in tumor cells is suggested to be an important regulator of malignant behavior in IHCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. The Liver Study Group of Japan. The 16th report: surveillance of primary liver cancer patients in National Registry. Kyoto: Liver Study Group of Japan (LCSGJ); 2005.

  2. Casavila FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga R, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997;185:429–36.

    Google Scholar 

  3. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg. 1995;130:270–6.

    Article  PubMed  CAS  Google Scholar 

  4. Roayaie S, Guarrena JV, Ye MQ, Thung SN, Emre S, Fishbein TM, et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg. 1998;187:365–72.

    Article  PubMed  CAS  Google Scholar 

  5. Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg. 1999;6:108–16.

    Article  PubMed  CAS  Google Scholar 

  6. Shimamura K, Kurosaki I, Sato D, Takano K, Yokoyama N, Sato Y, et al. Intrahepatic cholangiocarcinoma arising 34 years after excision of a type IV-A congenital choledochal cyst: report of a case. Surg Today. 2009;39:247–51.

    Article  PubMed  Google Scholar 

  7. Kacznski J, Hanson G, Wallerstedt S. Incidence, etiologic aspects and clinicopathological features in intrahepatic cholangiocarcinoma: a study of 51 cases from a low endemicity area. Acta Oncol. 1988;37:77–83.

    Google Scholar 

  8. Chu KM, Lai ECS, Al-Hadeede S, Arcilla CE Jr, Lo CM, Liu CL, et al. Intrahepatic cholangiocarcinoma. World J Surg. 1997;21:301–6.

    Article  PubMed  CAS  Google Scholar 

  9. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, et al. Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2003;10:259–64.

    Article  PubMed  Google Scholar 

  10. Yamamoto M, Takasaki K, Yoshikawa T. Extended resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg. 1999;6:117–21.

    Article  PubMed  CAS  Google Scholar 

  11. Langenbach RJ, Danenberg PV, Heidelberger C. Thymidylate synthase: mechanism of inhibition by 5-fluoro-2′-deoxyuridylate. Biochem Biophys Res Commun. 1972;48:1565–71.

    Article  PubMed  CAS  Google Scholar 

  12. Peters GJ, van der Wilt CL, van Triest B, Codacci-Pisanelli G, Johnston PG, van Groeningen CJ, et al. Thymidylate synthase and drug resistance. Eur J Cancer. 1995;31A:1299–305.

    Article  PubMed  CAS  Google Scholar 

  13. Heggie GD, Sommadossi JP, Cross DS, Huster WJ, Diasio RB. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine and bile. Cancer Res. 1987;47:2203–6.

    PubMed  CAS  Google Scholar 

  14. Etienne MC, Cheradame S, Fisschel JL, Formento P, Dassonville O, Rence N, et al. Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol. 1995;13:1663–70.

    PubMed  CAS  Google Scholar 

  15. Jiang W, Lu Z, He Y, Diasio RB. Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: implication in 5-fluorouracil-based chemotherapy. Clin Cancer Res. 1997;3:395–9.

    PubMed  CAS  Google Scholar 

  16. McLeod HL, Sludden J, Murray GI, Keenan RA, Davidson AI, Park K, et al. Characterization of dihydropyrimidine dehydrogenase in human colorectal tumor. Br J Cancer. 1998;77:461–5.

    Article  PubMed  CAS  Google Scholar 

  17. Ichikawa W, Takahashi T, Suto K, Nihei Z, Shirota Y, Shimizu M, et al. Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer. Int J Cancer. 2004;112:967–73.

    Article  PubMed  CAS  Google Scholar 

  18. Lassmann S, Hennig M, Rosenberg R, Nahrig J, Schreglmann J, Krause F, et al. Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors: correlation to tumor histopathology and clinical follow-up. Int J Colorectal Dis. 2006;21:238–47.

    Article  PubMed  Google Scholar 

  19. Liver Cancer Study Group of Japan. Classification of primary liver cancer. 1st English edn. Tokyo: Kanehara; 1997.

  20. Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, et al. Telomerase reverse transcriptase expression is increased early in the Barrett’s metaplasia, dysplasia, carcinoma sequence. Gastrointest Surg. 2000;4:135–42.

    Article  CAS  Google Scholar 

  21. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res. 1996;6:986–94.

    Article  PubMed  CAS  Google Scholar 

  22. Gibson UE, Geid CA, Williams PM. A novel method for real time quantitative RT-PCR. Genome Res. 1996;6:995–1011.

    Article  PubMed  CAS  Google Scholar 

  23. Fukui Y, Oka T, Nagayama S, Danenberg PV, Danenberg KD, Fukushima M. Thymidylate synthase, dihydropyrimidine dehydrogenase, orotate phosphoribosyltransferase mRNA and protein expression levels in solid tumors in large scale population analysis. Int J Mol Med. 2008;22:709–16.

    PubMed  CAS  Google Scholar 

  24. Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol. 1998;69:162–7.

    Article  PubMed  CAS  Google Scholar 

  25. Chou FF, Sheen-Chen SM, Chen YS, Chen MC, Chen CL. Surgical treatment of cholangiocarcinoma. Hepatogastroenterology. 1997;44:760–5.

    PubMed  CAS  Google Scholar 

  26. Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K. Hepatectomy for intrahepatic cholangiocarcinoma. Br J Cancer. 2001;88:1463–6.

    CAS  Google Scholar 

  27. El Rassi ZE, Partensky C, Scoazec JY, Henry L, Lombard-Bohas C, Maddern G. Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management. Eur J Surg Oncol. 1999;25:375–80.

    PubMed  CAS  Google Scholar 

  28. Valveade A, Bonhomme N, Fagas O, Sauvanet A, Flejou JF, Belghiti J. Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg. 1999;6:122–7.

    Article  Google Scholar 

  29. Otsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Cancer. 2002;89:1525–31.

    Google Scholar 

  30. Sasaki A, Aramaki M, Kawano K, Morii Y, Nakashima K, Yoshida T, et al. Intrahepatic peripheral cholangioma: mode of spread and choice of surgical treatment. Br J Cancer. 1998;85:1206–9.

    CAS  Google Scholar 

  31. Tuchman M, O’Dea RF, Ramnaraine LR, Mirkin BL. Pyrimidine base degradation in cultured murine C-1300 neuroblastoma cells and in situ tumors. J Clin Invest. 1988;81:425–30.

    Article  PubMed  CAS  Google Scholar 

  32. Fujiwaki R, Hata K, Nakayama K, Fukumoto M, Miyazaki K. Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer. J Clin Oncol. 2000;18:3946–51.

    PubMed  CAS  Google Scholar 

  33. Baba H, Teramoto K, Kawamura T, Mori A, Imamura M, Arii S. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers. Cancer Chemother Pharmacol. 2003;52:469–76.

    Article  PubMed  CAS  Google Scholar 

  34. Nii A, Shimada M, Ikegami T, Harino Y, Imura S, Morine Y, et al. Significance of dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expressions in hepatocellular carcinoma. Hepatol Res. 2009;39:274–81.

    Article  PubMed  CAS  Google Scholar 

  35. Nishi M, Shimada M, Utsunomiya T, Morine Y, Imura S, Ikemoto T, et al. Role of dihydropyrimidine dehydrogenase and thymidylate synthase expression in immunohistochemistry of intrahepatic cholangiocarcinoma. Hepatol Res. 2011;41:64–70.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Institute of Health Biosciences, University of Tokushima Graduate School, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan

    Yuji Morine, Mitsuo Shimada, Tohru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Jun Hanaka, Mami Kanamoto, Nobuhiro Kurita & Hidenori Miyake

Authors
  1. Yuji Morine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitsuo Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tohru Utsunomiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Satoru Imura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tetsuya Ikemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jun Hanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mami Kanamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Nobuhiro Kurita
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hidenori Miyake
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuji Morine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morine, Y., Shimada, M., Utsunomiya, T. et al. Role of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA in intrahepatic cholangiocarcinoma. Surg Today 42, 135–140 (2012). https://doi.org/10.1007/s00595-011-0054-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-011-0054-z

Keywords

Search

Navigation